Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55/YY1/sST2 signaling axis
11 May 2024 (15:40 - 17:00)
Organised by: 
About the speaker
Foundation for Health Research and Training, Murcia (Spain)
5 More presentations in this session
Doctor T. Egan Benova (Bratislava, SK)
Doctor S. Manea (Bucharest, RO)
Professor I. Murtaza (Islamabad, PK)
Access the full session
The Event
Heart Failure 2024
11 May 2024
15:40 CET
You may be interested in
Congress Presentation
Congress Session
